Claims
- 1. A method for treating patients having viral infections with surface manifestation on the skin, mucosa or eyes, comprising topically administering an effective amount for topical treatment of Product R to the area of the infections, wherein said Product R is a peptide nucleic acid composition that absorbs light at wavelengths 230 nm, 260 nm and 280 nm so as to result in 260 nm/280 mn absorption ratio of about 1.998 and 260 nm/230 nm absorption ratio of about 1.359, comprising molecules of nucleotides resulting form a plant RNA and peptides resulting from a mixture of casein, beef peptone and bovine serum albumin, said molecules having non-uniformly distributed molecular weights.
- 2. A method as in claim 1, wherein said area of the infections is said patients' skin.
- 3. A method as in claim 1, wherein said area of the infections is said patients' mucosa.
- 4. A method as in claim 1, wherein said area of the infections is said patients' eyes.
- 5. A method as in claim 1, wherein said viral infections with surface manifestation on the skin, mucosa or eyes are common warts.
- 6. A method as in claim 5, wherein said common warts are inflicted by HPV.
- 7. A method as in claim 1, wherein said viral infections with surface manifestation on the skin, mucosa or eyes are inflicted by HSV-1.
- 8. A method as in claim 1, wherein said viral infections with surface manifestation on the skin, mucosa or eyes are inflicted by HSV-2.
- 9. A method for treating patients having viral infections with surface manifestation on the skin, mucosa or eyes, comprising topically administering an effective amount for topical treatment of a composition comprising Product R and pharmaceutically acceptable carriers for topical administration, to the area of the infections, wherein said Product R is a peptide nucleic acid composition that absorbs light at wavelengths 230 nm, 260 nm and 280 mn so as to result in 260 nm/280 nm absorption ratio of about 1.998 and 260 nm/230 nm absorption ratio of about 1.359, comprising molecules of nucleotides resulting form a plant RNA and peptides resulting from a mixture of casein, beef peptone and bovine serum albumin, said molecules having non-uniformly distributed molecular weights.
- 10. A method as in claim 9, wherein said area of the infections is said patients' mucosa.
- 11. A method as in claim 9, wherein said area of the infections is said patients' skin.
- 12. A method as in claim 9, wherein said area of the infections is said patients' eyes.
- 13. The method as in claim 9, said composition comprising at least 50% by weight of Product R.
- 14. The method as in claim 9, said composition comprising at least 90% by weight of Product R.
- 15. The method as in claim 9, wherein said composition is in a form of solution.
- 16. The method as in claim 9, wherein said composition is in a form of ointment.
- 17. The method as in claim 9, wherein said composition is in a form of emulsified cream.
- 18. The method as in claim 9, wherein said composition is in a form of gels.
- 19. The method as in claim 9, wherein said composition is in a form of wax.
- 20. The method as in claim 9, wherein said composition is in a aerosol form.
- 21. A method as in claim 9, wherein said viral infections with surface manifestation on the skin, mucosa or eyes are common warts.
- 22. A method as in claim 21, wherein said common warts are inflicted by HPV.
- 23. A method as in claim 9, wherein said viral infections with surface manifestation on the skin, mucosa or eyes are inflicted by HSV-1.
- 24. A method as in claim 9, wherein said viral infections with surface manifestation on the skin, mucosa or eyes are inflicted by HSV-2.
RELATED APPLICATIONS
This application is a continuation-in-part of U.S. application Ser. No. 08/923,343, filed on Sep. 4, 1997 now abandoned which is a continuation-in-part of U.S. application Ser. No. 08/834,189 filed by Shalom Z. Hirschman on Apr. 15, 1997, entitled “TOPICAL TREATMENT OF SKIN DISEASES AND EYE AFFLICTIONS” now abandoned. The contents of application Ser. Nos. 08/923,343 and 08/834,189 are hereby incorporated by reference in their entirety.
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
08/923343 |
Sep 1997 |
US |
Child |
09/650554 |
|
US |
Parent |
08/834189 |
Apr 1997 |
US |
Child |
08/923343 |
|
US |